EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease

Cinzia Costa iD, Laura Bellingacci, Jacopo Canonichesi, Valentina Imperatore, Anna Aurora Taddei iD, Luis Zafra-Puerta iD, Nerea Iglesias-Cabeza, Paolo Prontera, Andrea Mancini, Massimiliano Di Filippo, Alessandro Tozzi, Katiuscia Martinello und 6 weitere

Epilepsia · 2026

DOI: 10.1111/epi.70024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Cinzia Costa und 17 weiteren Autor:innen. Beteiligte Einrichtung: Section of Neurophysiopathology S.M. della Misericordia Hospital, Section of Neurology and Laboratory of Experimental Neurology, Department of Medici…. Hauptthemen laut MEDLINE: Lafora Disease, Hippocampus, Neurons, Synapses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Stella Costa di Amalfi, Fondazione Malattie Rare Mauro Baschirotto BIRD Onlus, Spanish Ministry of Economy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Lafora disease (LD) is a rare progressive disorder caused by mutations in the EPM2A or EPM2B genes, characterized by the accumulation of Lafora bodies, drug‐resistant epilepsy, and cognitive decline. To investigate the early molecular mechanisms of LD, we studied electrophysiological changes in the dentate gyrus (DG) of the Epm2a R240X knock‐in mouse model at various ages.

Methods

Electrophysiological recordings measured neuronal membrane properties, epileptic‐like activity, epileptic thresholds, and synaptic plasticity in Epm2a R240X mice at 1, 3, and 12 months. We also employed Periodic Acid–Schiff (PAS) diastase staining, immunofluorescence, and Western blotting to detect Lafora bodies, amyloid beta deposition, and the expression of glutamate receptor subunits.

Results

Epileptic‐like activity began at 1 month and intensified with age. Aberrant long‐term potentiation (LTP) appeared at 3 months and worsened by 12 months. Notably, cannabidiol treatment reduced excitability and restored LTP in older mice, suggesting its potential therapeutic value. Significance The reversibility of synaptopathy, even at advanced stages, reinforces the importance of early detection of hyperexcitability and the development of effective therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lafora DiseaseHippocampusNeuronsSynapsesAnimalsMiceLong-Term PotentiationDisease Models, AnimalMice, TransgenicMaleDentate GyrusUbiquitin-Protein LigasesMice, Inbred C57BLProtein Tyrosine Phosphatases, Non-ReceptorGene Knock-In Techniques

Stichwörter der Autor:innen

Lafora diseasecannabidiolhippocampal synaptic dysfunctionneuronal hyperexcitabilitysynaptic plasticity

Substanzen

Ubiquitin-Protein LigasesProtein Tyrosine Phosphatases, Non-ReceptorEpm2a protein, mouse

Autor:innen und Institutionen

  • Section of Neurophysiopathology S.M. della Misericordia Hospital, Section of Neurology and Laboratory of Experimental Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Section of Physiology and Biochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Laboratory of Experimental Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Laboratory of Neurology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • PhD Program in Neuroscience, Universidad Autonòma de Madrid-Cajal Institute, Madrid, Spain.
  • Fondazione Malattie Rare Mauro Baschirotto BIRD Onlus, Longare, Italy.

ORCID-Profile: Cinzia Costa, Anna Aurora Taddei, Luis Zafra-Puerta, Miriam Sciaccaluga

Förderung

  • Associazione Stella Costa di Amalfi
  • Fondazione Malattie Rare Mauro Baschirotto BIRD Onlus
  • Spanish Ministry of Economy
  • Ministero della Salute
  • Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
  • Tatiana Pérez de Guzmán el Bueno Foundation
  • National Institute of Neurological Disorders and Stroke of the National Institutes of Health
  • AEVEL Foundation

Zitieren

APA

Costa, C., Bellingacci, L., Canonichesi, J., Imperatore, V., Taddei, A. A., Zafra-Puerta, L., Iglesias-Cabeza, N., Prontera, P., Mancini, A., Di Filippo, M., Tozzi, A., Martinello, K., Barzasi, M., Gardoni, F., Sánchez, M. P., Serratosa, J. M., Parnetti, L., & Sciaccaluga, M. (2026). Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease. Epilepsia. https://doi.org/10.1111/epi.70024

Vancouver

Costa C, Bellingacci L, Canonichesi J, Imperatore V, Taddei AA, Zafra-Puerta L, et al. Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease. Epilepsia. 2026. doi:10.1111/epi.70024

BibTeX
@article{Costa2026,
  author = {Costa, Cinzia and Bellingacci, Laura and Canonichesi, Jacopo and Imperatore, Valentina and Taddei, Anna Aurora and Zafra-Puerta, Luis and Iglesias-Cabeza, Nerea and Prontera, Paolo and Mancini, Andrea and Di Filippo, Massimiliano and Tozzi, Alessandro and Martinello, Katiuscia and Barzasi, Marta and Gardoni, Fabrizio and Sánchez, Marina P and Serratosa, José M and Parnetti, Lucilla and Sciaccaluga, Miriam},
  title = {Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1111/epi.70024}
}
Kostenlos starten →